Is there a role for probiotics in irritable bowel syndrome?

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.

Original languageEnglish (US)
Pages (from-to)S266-S269
JournalDigestive and Liver Disease
Issue numberSUPPL. 2
StatePublished - Dec 1 2006


  • Bifidobacteria
  • Irritable bowel syndrome
  • Lactobacilli
  • Probiotics
  • VSL#3

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Is there a role for probiotics in irritable bowel syndrome?'. Together they form a unique fingerprint.

Cite this